These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 26149884)

  • 1. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology.
    Hoang-Xuan K; Bessell E; Bromberg J; Hottinger AF; Preusser M; Rudà R; Schlegel U; Siegal T; Soussain C; Abacioglu U; Cassoux N; Deckert M; Dirven CM; Ferreri AJ; Graus F; Henriksson R; Herrlinger U; Taphoorn M; Soffietti R; Weller M;
    Lancet Oncol; 2015 Jul; 16(7):e322-32. PubMed ID: 26149884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options for central nervous system lymphomas in immunocompetent patients.
    Jahnke K; Thiel E
    Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic management of primary CNS lymphoma in immunocompetent patients.
    Reni M; Ferreri AJ
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):382-94. PubMed ID: 12113105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary CNS lymphoma--an update].
    Soussain C; Houillier C; Choquet S; Hoang-Xuan K
    Bull Cancer; 2014 Mar; 101(3):314-24. PubMed ID: 24691194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line autologous stem cell transplantation in primary CNS lymphoma.
    Brevet M; Garidi R; Gruson B; Royer B; Vaida I; Damaj G
    Eur J Haematol; 2005 Oct; 75(4):288-92. PubMed ID: 16146534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL).
    Hoang-Xuan K; Deckert M; Ferreri AJM; Furtner J; Gallego Perez-Larraya J; Henriksson R; Hottinger AF; Kasenda B; Lefranc F; Lossos A; McBain C; Preusser M; Roth P; Rudà R; Schlegel U; Soffietti R; Soussain C; Taphoorn MJB; Touitou V; Weller M; Bromberg JEC
    Neuro Oncol; 2023 Jan; 25(1):37-53. PubMed ID: 35953526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system.
    Illerhaus G; Müller F; Feuerhake F; Schäfer AO; Ostertag C; Finke J
    Haematologica; 2008 Jan; 93(1):147-8. PubMed ID: 18166803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary central nervous system (CNS) lymphoma in immunocompetent patients.
    Plasswilm L; Herrlinger U; Korfel A; Weller M; Küker W; Kanz L; Thiel E; Bamberg M
    Ann Hematol; 2002 Aug; 81(8):415-23. PubMed ID: 12223997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary CNS lymphoma in immunocompetent patients.
    Sierra del Rio M; Rousseau A; Soussain C; Ricard D; Hoang-Xuan K
    Oncologist; 2009 May; 14(5):526-39. PubMed ID: 19433528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
    Colombat P; Lemevel A; Bertrand P; Delwail V; Rachieru P; Brion A; Berthou C; Bay JO; Delepine R; Desablens B; Camilleri-Broët S; Linassier C; Lamy T
    Bone Marrow Transplant; 2006 Sep; 38(6):417-20. PubMed ID: 16951691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary central nervous system lymphoma: diagnosis, management and current topics].
    Arita N
    No To Shinkei; 2004 Mar; 56(3):195-203. PubMed ID: 15112444
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
    Bierman P; Giglio P
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):597-609, v. PubMed ID: 16083825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of primary central nervous system lymphoma in the immunocompetent patient].
    Sierra Del Rio M; Benouaich-Amiel A; Psimaras D; Dehais C; Hoang-Xuan K
    Rev Neurol (Paris); 2008; 164(6-7):569-74. PubMed ID: 18565356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary CNS lymphoma and neurologic complications of hematologic malignancies.
    Nayak L; Pentsova E; Batchelor TT
    Continuum (Minneap Minn); 2015 Apr; 21(2 Neuro-oncology):355-72. PubMed ID: 25837901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary CNS lymphoma: 5-year survival in relation to dosage of methotrexate and radiation.
    Meyer MA
    Ann Hematol; 2004 Aug; 83(8):549. PubMed ID: 15052370
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary central nervous system lymphoma in immunocompetent patients.
    Ferreri AJ; Reni M; Villa E
    Cancer Treat Rev; 1995 Sep; 21(5):415-46. PubMed ID: 8556717
    [No Abstract]   [Full Text] [Related]  

  • 17. Current management of primary central nervous system lymphoma.
    Schultz CJ; Bovi J
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):666-78. PubMed ID: 20159361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis and management of primary CNS lymphoma.
    Roth P; Korfel A; Martus P; Weller M
    Expert Rev Anticancer Ther; 2012 May; 12(5):623-33. PubMed ID: 22594897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable outcome of primary CNS anaplastic large cell lymphoma in an immunocompetent patient.
    Ozkaynak MF
    J Pediatr Hematol Oncol; 2009 Feb; 31(2):128-30. PubMed ID: 19194199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [T-type primary lymphoma of the central nervous system in immunocompetent patients].
    Barrena-Caballo MR; Blanch-Labrador M; Giménez-Mas JA; Alberdi-Viñas J; Pascual-Piazuelo M; Zubiri-Ara L
    Rev Neurol; 2003 Jan 16-31; 36(2):125-30. PubMed ID: 12589598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.